Combination therapy of phosphatidylserine liposome with cyclosporine A improves nephrotoxicity and attenuates delayed-type hypersensitivity response.
Sign Up to like & getrecommendations! Published in 2020 at "Life sciences"
DOI: 10.1016/j.lfs.2020.118780
Abstract: This study aimed to evaluate the antioxidant capacity of phosphatidylserine liposome (PS) against oxidative stress due to Cyclosporine A (CsA) and their concurrent administration on the attenuation of immune response. The effect of oral PS… read more here.
Keywords: delayed type; phosphatidylserine liposome; response; cyclosporine ... See more keywords